+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Isothermal Nucleic Acid Amplification Technology Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895126
The global isothermal nucleic acid amplification technology market was valued at USD 4.6 billion in 2023, driven by increasing demand for rapid and accurate molecular diagnostic tools across the globe. The market size is anticipated to grow at a CAGR of 11.3% during the forecast period of 2024-2032 to achieve a value of USD 12.1 billion by 2032.

Isothermal Nucleic Acid Amplification Technology: Introduction

Isothermal nucleic acid amplification technology is a molecular biology technique that allows the rapid and sensitive amplification of specific DNA or RNA sequences at a constant temperature, typically between 37 to 65 degrees Celsius. Unlike traditional polymerase chain reaction (PCR) methods that require temperature cycling, isothermal amplification techniques operate at a single temperature, eliminating the need for expensive thermal cycling equipment.

The principle behind isothermal nucleic acid amplification is the use of specialized enzymes or enzymatic processes that can continuously and efficiently amplify target nucleic acid sequences. These techniques offer several advantages over traditional PCR, including simplicity, speed, and the ability to perform amplification in resource-limited settings.

Key Trends in the Isothermal Nucleic Acid Amplification Technology Market

Key trends in the isothermal nucleic acid amplification technology market reflect the growing demand for rapid and sensitive molecular diagnostic tools and the advancements in the field of nucleic acid amplification. Some key trends in the market include:

  • Increasing Adoption in Point-of-Care Testing: Isothermal nucleic acid amplification technologies are well-suited for point-of-care testing (POCT) due to their simplicity, speed, and compatibility with portable or handheld devices. The market is witnessing a rising demand for POCT platforms that utilize isothermal amplification techniques for rapid and on-site diagnosis of infectious diseases, genetic disorders, and other conditions.
  • Development of Multiplex Assays: Multiplex assays that can simultaneously detect multiple targets in a single reaction are gaining popularity in the market. Isothermal nucleic acid amplification technologies are being adapted to enable multiplexing, allowing for the detection of multiple pathogens or genetic markers in a single sample.
  • Integration with Portable and Handheld Devices: The market is witnessing an integration of isothermal nucleic acid amplification technologies with portable and handheld devices. This trend enables point-of-care testing in resource-limited settings, field-based applications, and remote areas where access to laboratory infrastructure is limited.
  • Expansion in Molecular Diagnostics: Isothermal nucleic acid amplification technologies are increasingly being utilized in the field of molecular diagnostics. These techniques play a crucial role in detecting infectious diseases, including viral, bacterial, and parasitic infections. They also find application in genetic testing for the identification of mutations, genetic variants, and disease-associated markers.

Isothermal Nucleic Acid Amplification Technology Market Segmentations

The market can be categorized into technology, products, target type, and region.

Market Breakup by Technology

  • Helicase-dependent Amplification (HDA)
  • Nicking Enzyme Amplification Reaction (NEAR)
  • Loop-mediated Isothermal Amplification (LAMP)
  • Strand Displacement Amplification (SDA)
  • Nucleic Acid Sequence-based Amplification (NASBA)
  • Transcription Mediated Amplification (TMA)
  • Single Primer Isothermal Amplification (SPIA)
  • Other Technologies

Market Breakup by Products

  • Instruments
  • Reagent

Market Breakup by Target Type

  • Hospitals
  • Research Organisation
  • Other End Users

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Isothermal Nucleic Acid Amplification Technology Market Overview

The isothermal nucleic acid amplification technology market is experiencing significant growth and is expected to continue expanding in the coming years. Isothermal amplification techniques have gained prominence as powerful tools for molecular diagnostics, research, and various applications in healthcare, agriculture, and environmental monitoring. The market for isothermal nucleic acid amplification technology is witnessing robust growth due to the increasing demand for rapid and accurate molecular diagnostic tools. The advantages of isothermal amplification techniques, such as simplicity, speed, and compatibility with portable devices, have fueled their adoption in point-of-care testing and decentralized settings. The market is driven by the need for early disease detection, efficient monitoring of infectious diseases, and the growing prevalence of genetic disorders.

The adoption of isothermal nucleic acid amplification technologies is expanding in emerging markets, particularly in Asia Pacific, Latin America, and Africa. These regions have a growing demand for affordable and accessible diagnostic solutions, especially in remote or resource-limited settings. The market players are focusing on expanding their presence in these regions through collaborations, partnerships, and distribution agreements.

Key Players in the Isothermal Nucleic Acid Amplification Technology Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in isothermal nucleic acid amplification technology market are as follows:

  • Becton Dickinson and Company
  • Qiagen NV
  • bioMerieux
  • Abbot Laboratories
  • General ELectric
  • OptiGene Limited
  • Thermo Fisher Scientific
  • Genomtec
  • BioSystems
  • PCR Biosystems
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Isothermal Nucleic Acid Amplification Technology Market Overview
3.1 Global Isothermal Nucleic Acid Amplification Technology Market Historical Value (2017-2023)
3.2 Global Isothermal Nucleic Acid Amplification Technology Market Forecast Value (2024-2032)
4 Global Isothermal Nucleic Acid Amplification Technology Market Landscape
4.1 Global Isothermal Nucleic Acid Amplification Technology: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Isothermal Nucleic Acid Amplification Technology: Product Landscape
4.2.1 Analysis by Isotope
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Isothermal Nucleic Acid Amplification Technology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Isothermal Nucleic Acid Amplification Technology Market Segmentation
6.1 Global Isothermal Nucleic Acid Amplification Technology Market by Technology
6.1.1 Market Overview
6.1.2 Helicase-dependent Amplification (HDA)
6.1.3 Nicking Enzyme Amplification Reaction (NEAR)
6.1.4 Loop-mediated Isothermal Amplification (LAMP)
6.1.5 Strand Displacement Amplification (SDA)
6.1.6 Nucleic Acid Sequence-based Amplification (NASBA)
6.1.7 Transcription Mediated Amplification (TMA)
6.1.8 Single Primer Isothermal Amplification (SPIA)
6.1.9 Other Technologies
6.2 Global Isothermal Nucleic Acid Amplification Technology Market by Products
6.2.1 Market Overview
6.2.2 Instruments
6.2.3 Reagent
6.3 Global Isothermal Nucleic Acid Amplification Technology Market by Target Type
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Research Organisation
6.3.4 Other End Users
6.4 Global Isothermal Nucleic Acid Amplification Technology Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Isothermal Nucleic Acid Amplification Technology Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Isothermal Nucleic Acid Amplification Technology Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America l Isothermal Nucleic Acid Amplification Technology Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Becton Dickinson and Company
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Qiagen NV
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 bioMerieux
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Abbot Laboratories
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 General ELectric
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 OptiGene Limited
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Thermo Fisher Scientific
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Genomtec
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 BioSystems
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 PCR Biosystems
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Becton Dickinson and Company
  • Qiagen NV
  • bioMerieux
  • Abbot Laboratories
  • General ELectric
  • OptiGene Limited
  • Thermo Fisher Scientific
  • Genomtec
  • BioSystems
  • PCR Biosystems

Methodology

Loading
LOADING...